company background image
600557 logo

Jiangsu Kanion PharmaceuticalLtd SHSE:600557 Stock Report

Last Price

CN¥15.16

Market Cap

CN¥8.8b

7D

-5.3%

1Y

-25.4%

Updated

27 Jul, 2024

Data

Company Financials +

Jiangsu Kanion Pharmaceutical Co.,Ltd.

SHSE:600557 Stock Report

Market Cap: CN¥8.8b

Jiangsu Kanion Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jiangsu Kanion PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥15.16
52 Week HighCN¥24.09
52 Week LowCN¥13.36
Beta0.36
11 Month Change-2.19%
3 Month Change-23.43%
1 Year Change-25.36%
33 Year Change46.90%
5 Year Change2.50%
Change since IPO449.09%

Recent News & Updates

Here's Why Jiangsu Kanion PharmaceuticalLtd (SHSE:600557) Has Caught The Eye Of Investors

May 21
Here's Why Jiangsu Kanion PharmaceuticalLtd (SHSE:600557) Has Caught The Eye Of Investors

Shareholders Can Be Confident That Jiangsu Kanion PharmaceuticalLtd's (SHSE:600557) Earnings Are High Quality

Apr 25
Shareholders Can Be Confident That Jiangsu Kanion PharmaceuticalLtd's (SHSE:600557) Earnings Are High Quality

Recent updates

Here's Why Jiangsu Kanion PharmaceuticalLtd (SHSE:600557) Has Caught The Eye Of Investors

May 21
Here's Why Jiangsu Kanion PharmaceuticalLtd (SHSE:600557) Has Caught The Eye Of Investors

Shareholders Can Be Confident That Jiangsu Kanion PharmaceuticalLtd's (SHSE:600557) Earnings Are High Quality

Apr 25
Shareholders Can Be Confident That Jiangsu Kanion PharmaceuticalLtd's (SHSE:600557) Earnings Are High Quality

Jiangsu Kanion Pharmaceutical Co.,Ltd.'s (SHSE:600557) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

Mar 04
Jiangsu Kanion Pharmaceutical Co.,Ltd.'s (SHSE:600557) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHSE:600557) Shares Fly 34% But Investors Aren't Buying For Growth

Mar 04
Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHSE:600557) Shares Fly 34% But Investors Aren't Buying For Growth

Shareholder Returns

600557CN PharmaceuticalsCN Market
7D-5.3%-4.0%-2.8%
1Y-25.4%-18.8%-21.0%

Return vs Industry: 600557 underperformed the CN Pharmaceuticals industry which returned -18.8% over the past year.

Return vs Market: 600557 underperformed the CN Market which returned -21% over the past year.

Price Volatility

Is 600557's price volatile compared to industry and market?
600557 volatility
600557 Average Weekly Movement4.4%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement5.8%
10% most volatile stocks in CN Market9.0%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 600557's share price has been volatile over the past 3 months.

Volatility Over Time: 600557's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19755,443Yongchun Yangwww.kanion.com

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others.

Jiangsu Kanion Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Jiangsu Kanion PharmaceuticalLtd's earnings and revenue compare to its market cap?
600557 fundamental statistics
Market capCN¥8.81b
Earnings (TTM)CN¥526.44m
Revenue (TTM)CN¥4.57b

16.7x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600557 income statement (TTM)
RevenueCN¥4.57b
Cost of RevenueCN¥1.19b
Gross ProfitCN¥3.38b
Other ExpensesCN¥2.86b
EarningsCN¥526.44m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.91
Gross Margin73.97%
Net Profit Margin11.51%
Debt/Equity Ratio0%

How did 600557 perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

40%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.